BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc. – The increasing incidences of atopic dermatitis among a considerable chunk of the global populace may prove to be a growth booster for the atopic dermatitis treatment market during the forecast period of 2021-2031

Wilmington, Delaware, United States, Transparency Market Research Inc. – The multiple myeloma market is likely to witness promising growth across the forecast period of 2021-2031 on the back of the growing prevalence of blood cancer around the world.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The rising number of chronic diseases found globally will bring tremendous growth opportunities for the medication management market. Patients suffering from chronic conditions such as diabetes, and cardiovascular disease require attention and hospitalization.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The increasing awareness about various therapeutic application of biotherapy stands as a key factor augmenting the growth of the global single-use technology for biopharmaceuticals market.

Emtora Biosciences announced it has been awarded a $16.9M non-dilutive grant from the Cancer Prevention & Research Institute of Texas to advance the clinical and product development of its lead program, eRapaTM, an encapsulated form of rapamycin, for the treatment of Familial Adenomatous Polyposis.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Surgical devices are specifically designed instruments or performing specific actions or carrying out desired effects during a surgery or operation.

Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, announced it has granted inducement awards to new employees.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences.

Deciphera Pharmaceuticals, Inc. announced that in connection with the hiring of Lisa Amaya Price, Senior Vice President and Chief Human Resources Officer, the Compensation Committee of Deciphera’s Board of Directors approved the grant of a stock option to purchase 100,000 shares of Deciphera’s common stock and 25,000 restricted stock units to Ms. Amaya Price with a grant date of August 15, 2022.

The RCMP Academy is pleased to highlight that the first official paper was released for the RCMP Longitudinal PTSD Study.